CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian Study
Article de revueClin Lymphoma Myeloma Leuk, 23 (3), 2023.
Real-World Budget Impact of Listing a Biosimilar of Rituximab
Article de revueCan J Hosp Pharm, 73 (1), 2020.
Signaler des ajouts ou des modifications